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PW1 is a mediator of p53 and TNFa signaling pathways previously identified in a screen to isolate muscle stem cell regulators. We
generated transgenic mice carrying a C-terminal deleted form of PW1 (DPW1) which blocks p53-mediated cell death and TNFa-mediated
NFnB activation fused to the myogenin promoter. Embryonic/fetal muscle development appears normal during transgene expression,
however, postnatal transgenic pups display severe phenotypes including runtism, reduced muscle mass and fiber diameters resembling
atrophy. Atrogin-1, a marker of skeletal muscle atrophy, is expressed postnatally in transgenic mice. Electron microscopic analyses of
transgenic muscle reveal a marked decrease in quiescent muscle satellite cells suggesting a deregulation of postnatal stem cells. Furthermore,
transgenic primary myoblasts show a resistance to the effects of TNFa upon differentiation. Taken together, our data support a role for PW1
and related stress pathways in mediating skeletal muscle stem cell behavior which in turn is critical for postnatal muscle growth and
homeostasis. In addition, these data reveal that postnatal stem cell behavior is likely specified during early muscle development.
D 2005 Elsevier Inc. All rights reserved.
Keywords: Satellite cells; Stem cells; Skeletal muscle; Development; Mouse; PW1/Peg3; p53; TNF; AtrophyIntroduction
Vertebrate trunk and limb musculature originates from
founder cells that become committed to the skeletal muscle
lineage in the somites (Cinnamon et al., 1999; Ordahl and
Le Douarin, 1992). Successive waves of myogenesis occur
during fetal and postnatal development leading to the
formation of adult muscle fibers (Stockdale, 1992). While
the origin of embryonic myoblasts has been well defined
(Gross et al., 2000; Tajbakhsh and Cossu, 1997; Tajbakhsh
et al., 1996, 1997), the origin(s) of secondary (fetal)
myoblasts and satellites cells (postnatal) remains unclear0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Pax7 plays a critical role in the establishment and/or
maintenance of satellite cells. Specifically, Pax7 mutant
mice are born with normal musculature but display severely
compromised postnatal growth and lack muscle satellite
cells (Seale et al., 2000). Curiously, these mice show a
compensatory increase in the number of hematopoietic stem
cells residing in the skeletal muscle tissue (Seale et al.,
2000). While these data reveal that Pax7 is required for the
establishment and/or maintenance of satellite cells, it
remains unclear if satellite cells are derived from a resident
population of pluripotent stem cells in postnatal muscle or if
they are derived from the initial population of embryonic
and/or fetal myoblasts. While regeneration of adult skeletal
muscle recapitulates many aspects of embryonic/fetal myo-
genesis, results from MyoD-deficient mice reveal a specific
role for MyoD during regeneration (Kablar et al., 1997;
White et al., 2000) suggesting that the postnatal myogenic281 (2005) 171–183
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(Parker et al., 2003; Sabourin and Rudnicki, 2000, for
review). Stimuli that lead to recruitment of muscle stem
cells include mechanical damage, denervation and inflam-
matory cytokines all of which are normally part of postnatal
life and not prenatal development (Darr and Schultz, 1987;
Fong et al., 1989; Hill et al., 2003; Li, 2003; Musaro et al.,
2004; Rodrigues Ade et al., 2002).
In an effort to identify genes expressed during early
mesoderm-to-skeletal muscle commitment, we used a
differential screening approach which resulted in the
isolation of a gene called PW1/Peg3 (Relaix et al., 1996).
PW1 encodes for a large protein (~210 kD) containing 12
zinc fingers and multiple proline-rich repeat motifs. The
pattern of PW1 expression during mouse development is
complex, however expression initiates in the primitive
streak (mesoderm) and is subsequently downregulated in
mesodermally derived tissues as they differentiate with the
exception of skeletal muscle which maintains moderate
levels perinatally which later decline in the adult (Relaix et
al., 1996). Levels of PW1 expression are high in most
myogenic cell lines as well as in primary myoblasts
obtained from postnatal muscle (Coletti et al., 2002; Relaix
et al., 1996). Subsequent studies have revealed that PW1
participates in the TNFa–NFnB signaling cascade through
direct association with TRAF2 (Relaix et al., 1998). In
addition, PW1 has been identified as a p53-induced gene in
fibroblasts induced to undergo cell death (Relaix et al.,
2000). In both these contexts, a C-terminal deleted form of
PW1 (DPW1) is a potent blocker of TNFa-mediated NFnB
activation and p53-mediated cell death (Relaix et al., 1998,
2000). TNFa is one of several potent inflammatory
cytokines that is responsible for muscle wasting (cachexia)
(Argiles and Lopez-Soriano, 1999; Fong et al., 1989; Tracey
et al., 1988) and is also capable of blocking terminal
differentiation of myogenic cells in vitro (Coletti et al.,
2002). We have recently demonstrated that PW1 is required
to mediate the TNFa block of differentiation in myoblasts
through the recruitment of p53 downstream effectors
including bax and caspase 9 (Coletti et al., 2002). A role
for PW1 in muscle stem cells in vivo comes from a recent
study in which PW1 expression was found to be almost
absent in MyoD mutant myoblasts compared to the high
levels found in wildtype myoblasts (Seale et al., 2004a). As
these myoblasts are deficient in participating in normal
muscle regeneration, these data suggest that PW1 may
participate in a regulatory process controlling stem cell
maintenance and stress responses.
In an effort to determine the in vivo function of PW1 as
well as the potential role of PW1-mediated pathways during
muscle development, we generated transgenic mice carrying
DPW1 under the control of the myogenin promoter
(Myo1565) (Cheng et al., 1992; Edmondson et al., 1992).
We show that a transient expression of DPW1 during
embryonic development does not interfere with embryonic
and fetal muscle development, however transgenic micedisplay a profound failure in postnatal growth similar to the
phenotype seen in Pax7 mutant mice (Seale et al., 2000). In
contrast to Pax7 mutant mice which show either an absence
or a marked decrease in satellite cells (Oustanina et al.,
2004; Seale et al., 2000), we observe that satellite cells are
formed in transgenic mice but they are not quiescent. We
show that satellite cells and differentiating myoblasts are
found in clusters with PW1 expressing cells found outside
of the basal lamina suggesting a common origin for these
stem cells. Furthermore, transgenic muscle shows aberrant
high levels of Atrogin-1 expression consistent with the
atrophic muscle phenotype observed. Whereas wildtype
primary cultures of myoblasts are inhibited to differentiate
in the presence of TNFa, primary transgenic myoblasts are
resistant to exogenous TNFa suggesting that the transgene
induces a permanent change in stem cell behavior. Taken
together, this study demonstrates that PW1-mediated cell
stress response pathways are critical for early postnatal stem
cell behavior and postnatal muscle growth and homeostasis.
Our data also indicate that the postnatal muscle stem cell
population is likely specified during somitogenesis.Materials and methods
Transgenic construct
Transgenic mice carrying a myogenin promoter frag-
ment-DPW1-IRESLacZ fusion gene were generated by
pronuclear injection. The DPW1 sequence corresponding
to the N-terminal portion of the PW1 protein (aa residues 1
to 592) (Relaix et al., 1998, 2000) was cloned under control
of a regulatory sequence derived from nucleotides 1565 to
+18 (relative to the transcription start site) of the mouse
myogenin promoter (Myo1565) (Cheng et al., 1992;
Edmondson et al., 1992) (gift from Dr. E.N. Olson,
University of Texas, Houston). Additional sequences were
added to optimize expression in vivo (Fig. 1) including the
rabbit h-globin intron linked to the IRES-LacZ-SV40
polyadenylation signal sequence (from plasmid 601DW58,
gift from Dr. T. Lufkin, Mount Sinai School of Medicine,
New York) which allows for efficient translation of h-
galactosidase concomitant with transgene expression (Li et
al., 1997). A GTI-2 promoter linked to the neomycin gene
and a SV40 polyadenylation signal were also cloned
downstream of the entire construct for potential selection
(a gift from Dr. T. Lufkin, Mount Sinai School of Medicine,
New York).
Transfection procedures, cell culture and TNFa treatment
In vitro analysis of transgene expression was performed
by transfection of the C2C12 myogenic line with the
construct or the control backbone (without DPW1) using
FuGene 6 reagent (Roche Molecular Biochemicals-Boeh-
ringer Mannheim, Indianapolis, IN) according to the
Fig. 1. Expression of the myog-DPW1 transgene in vitro and in vivo. (a) Diagram of full length coding portion of the PW1 cDNA and DPW1 cDNA. The zinc
fingers are represented as dark blue boxes, the RER and proline-rich sequences are indicated as light blue boxes. Schematic diagram of the transgenic construct
(distances are not to scale) in which nt 35 to +1900 (aa 1–592) was placed downstream of the myogenin promoter (myo 1565) in order to obtain muscle-
specific expression. A h-globin intron region and an IRES-LacZ-polyA sequence, h-galactosidase (LacZ) and additional sequences were placed into the
transgene as described in the Materials and methods. (b) C2C12 cells were transfected with myog-DPW1-LacZ construct or myog-LacZ and h-galactosidase
activity was measured under growth (GM) and differentiation (DM) conditions. As expected, transgene expression was detected by 1 day in DM and increased
by 2 days. We did not see any obvious difference between levels and numbers of cells that expressed DPW1 (myog-DPW1-LacZ) or the construct carrying the
IRES lacZ alone (or myog-LacZ) suggesting that DPW1 expression has no obvious deleterious effect under these conditions. (c) Wildtype (wt) and transgenic
(tg) embryos at embryonic day 10.5 (ED10.5). h-galactosidase positive cells were detected in the somite, however the number of cells was lower than expected
and declined steadily during myotome differentiation. We note that we either observed strong muscle-specific staining or a very weak specific staining in
transgenic embyros.
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differentiated as previously described (Coletti et al., 2002).
The h-galactosidase activity was determined as described
below.
Primary myoblasts were isolated as previously described
(Coletti et al., 2002), from fore- and hindlimb muscles of 6
days postnatal founder pups. Primary cultures were main-
tained on collagen-coated dishes in Ham’s F10 (Invitrogen,
Carlsbad, CA) supplemented with 20% FCS, 200 U/ml
penicillin and 200 mg/ml streptomycin (GM). Fresh bFGF
(Boehringer) (2.5 ng/ml) was added every other day. All
experiments were done using cultures passaged less than 10
times. For immunohistochemistry, cells were replicate
plated onto 6 different collagen-coated coverslips at the
concentration of 5000 cells/500 Al for wt and 2500 cells/500
Al for transgenic primary myoblasts. Primary myoblasts
were differentiated in DMEM supplemented with 5% horse
serum and antibiotics (DM).
Cells were treated with 50 ng/ml of recombinant mouse
TNFa (Roche Molecular Biochemicals-Boehringer Man-
nheim, Indianapolis, IN) and analyzed after 3 days in DM.
Myosin was detected using the MF20 antibody (Coletti et
al., 2002). Quantitative analysis of differentiation was
determined by counting the number of nuclei in MF20-
positive cells and expressing this as a percentile of the total
number of nuclei from at least 5 fields per experiment (N50
nuclei/field). Each experiment was performed in triplicate
on 3 independent primary cultures obtained from three
different transgenic pups showing a phenotype at 6 days
after birth.
Generation of transgenic mice and genotype
Transgenic mice were generated by standard pronuclear
injection procedures using the Mouse Genetics Shared
Research Facility at the Mount Sinai School of Medicine,
New York. The transgene DNA construct (Fig. 1) was
released from the plasmid by digestion with SalI. The 10
Kb fragment was gel purified using a Qiagen agarose gel
extraction kit according to the manufacturer’s instructions
(Qiagen, Valencia, CA), eluted with the injection buffer
(10mM Tris, pH 7.4, 0.2mM EDTA) and filtered twice
through a 0.22 Am filter (Millex-GV4, Millipore). The
DNA was then injected at a final concentration of 2 ng/Al
in the pronuclei of fertilized F2 (CBAxC57/Bl6) mouse
eggs according to the protocol of Hogan et al. (1994).
Injected embryos were reimplanted into the oviducts of
pseudopregnant Swiss Webster females and assigned a
gestational age of 0.5 days. Transgenic animals were
identified by Southern blot of genomic DNA extracted
from yolk sac of transient embryos or from tail-biopsies of
the pups. 10 Ag of genomic DNA was digested overnight
at 378C in a 50 Al solution with the restriction enzyme
BamHI and the appropriate buffer from New England
Biolabs, Beverly, MA. DNA was transferred to a nylon
membrane Hybond-N+(Amersham, Piscataway, NJ) andhybridized with a random-primed 32PdCTP-labeled LacZ
BamHI fragment.
Detection of b-galactosidase activity
Transgenic and wildtype embryos or hindlimb muscles
were retrieved in ice-cold 1 PBS and fixed for 5–10 min at
room temperature in a formaldehyde–glutaraldehyde solu-
tion (2% formaldehyde, 0.2% glutaraldehyde, 0.02% Non-
idet P-40 (NP-40) and 0.01% sodium deoxycholate in PBS).
For determination of the h-galactosidase activity on C2C12
cells, the medium was gently removed and the cells were
washed in PBS at room temperature before fixation for 2
min. After fixation, tissues and cells were rinsed briefly and
stained using procedures described previously (Degenhardt
et al., 2002; Rentschler et al., 2001).
Histology, electron microscopy and immunofluorescence
For analysis by TEM (transmission electron microscopy),
hindlimb muscles were removed, immediately placed into
cold 1 PBS and fixed overnight in 2% glutaraldehyde
solution at 48C. Tissues were post-fixed in osmium tetroxide
and embedded in epon resin. Semithin sections (1–2 Am
thickness) were collected onto subbed slides and stained
with Toluidine Blue for standard light microscopic analysis.
Ultrathin sections of 70–90 nm were collected onto copper
grids and examined by electron microscopy (JOEL instru-
ments). A minimum of 10 different fields from at least 3
sections were analyzed from 3 different wildtype and
transgenic 6 days postnatal hindlimbs. We then counted
all the nuclei in each field and classified them according to
the categories of myonuclei, sublamina non-myonuclei
(presumably satellite cells) and interstitial cells. We did
not include vascular cells in these counts. We then
normalized our counts to the total number of fibers in each
field and present the data as a percentage or proportion of
this population. The classification of dactivatedT versus
quiescent satellite cell was made based upon criteria
outlined previously (Mauro, 1970). In brief, quiescent
satellite cells are sublamina but are separated from the
myofiber by a distinct plasma membrane, have condensed
heterochromatic nuclei, few to no extensions and little
cytoplasm with few organelles. If a sublaminal cell did not
have at least 2 of these characteristics, we classified the cell
as activated.
Hindlimb muscles from 6 days pups were fixed overnight
in freshly prepared 4% paraformaldehyde in 1 PBS and
embedded in paraffin following procedures described else-
where (Sassoon and Rosenthal, 1993). Cross-sections of 8
Am were prepared using a Leica RM2125 microtome at the
midanterior–posterior level of the hindlimb, collected on
gelatin subbed slides and stained with hematoxylin and
eosin.
Fore and hindlimb muscles from 6 days postnatal pups
were snap frozen in isopentane cooled liquid nitrogen. Five
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Instruments Cryostat (Bright, UK) onto gelatin subbed
slides, fixed in 4% paraformaldehyde and permeabilized in
methanol (6 min at 208C). A citric acid antigen retrieval
protocol was used to facilitate Pax7 immunostaining. Slides
were heated in a 908C solution of 0.01 M citric acid (pH 6)
two times for 5 min in a microwave oven, followed by
cooling in the same solution for 10 min. After washing with
PBS, sections were blocked in 2% BSA in PBS (block).
Anti-PW1 antibody polysera (Coletti et al., 2002; Relaix et
al., 1996) was diluted 1/3000 in block. Anti-pax7 mono-
clonal antibody (Developmental Studies Hybridoma Bank,
University of Iowa) and anti-laminin polysera (Sigma, St.
Louis MO) were diluted 1/20 and 1/50 respectively in
Roche Blocking reagent (cat 1096176 Roche Molecular
Biochemicals-Boehringer Mannheim, Indianapolis, IN).
Antibody binding was visualized by using goat anti-rabbit
Alexa 488 and goat anti-mouse IgG1 Alexa 568 (Molecular
probes) and CY5-conjugated goat anti-rabbit IgG (Jackson
Lab). The slides were mounted and observed with a Leica
TCS-SP(UV) confocal microscope at the MSSM-Micro-
scopy Shared Resource Facility.
Northern blotting
For Northern blot analysis, total RNA was isolated
from hindlimb muscles (ages indicated on the blot) by
using TRIzol (Life Technologies, Grand Island, NY)
reagent, following the manufacturer’s instructions. 10 Ag
of total RNA samples was separated by electrophoresis on
a denaturing 1.2% agarose/1 MOPS/6% formaldehyde
gel, transferred to a nylon membrane Hybond-N+(Amer-
sham, Piscataway, NJ) and UV cross-linked. Northern
blots were hybridized with 6  106 d.p.m./ml of a
random-primed 32P-dCTP-labeled gel-purified KpnI/XbaI
fragment of the Atrogin-1 coding sequence (bp 1500–
2368) (Gomes et al., 2001). Blots were stripped and
rehybridized with the total GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) cDNA as standard control of
RNA loading. Prehybridization for 2 h and an overnight
hybridization were performed at 428C in Hybrisol I
(Chemicon International, Temecula, CA) solution contain-
ing 50% formamide, 6  SSC. Washes were done twice
at 428C in 2  SSC/0.1% SDS for 5 min, one time in
0.2  SSC/0.1% SDS for 15 min and in 0.1  SSC/
0.1% SDS for 15 min at 608C. Northern blots were then
exposed at 208C in the presence of a Biomax
intensifying screen (Kodak, New Haven, CT).Results
Transgenic construct
PW1 encodes a large protein (1380 aa residues) contain-
ing 12 Krqpple-like zinc fingers organized into threeclusters (Relaix et al., 1996 and Fig. 1). The N-terminal
portion of PW1 (spanning residues 1–592) contains an
arginine-rich motif (RER) and a proline-rich domain as well
as a cluster of 3 zinc fingers and one isolated zinc finger
(Fig. 1). Whereas PW1 can activate NFnB and mediate p53-
mediated cell death, DPW1 blocks these pathways (Relaix et
al., 1998, 2000). In order to generate transgenic mice
expressing DPW1 directed specifically to the muscle
lineage, we placed a cDNA encoding residues 1–592 of
PW1 in an expression vector carrying the myogenin
promoter (Myo1565; Cheng et al., 1992) as shown in
Fig. 1. We chose the myogenin promoter since PW1 and
myogenin are both expressed in the early myogenic
compartments of the embryo (Cheng et al., 1992; Relaix
et al., 1996) and the specific regulatory element used had
been shown to drive MRF4 transgene expression in a similar
setting (Zhu and Miller, 1997). In order to follow expression
of the transgene, we cloned the h-galactosidase gene
downstream of an internal ribosome entry sequence (IRES)
derived from the encephalomyocarditis virus to generate a
bicistronic mRNA encoding both cDNAs. This system has
been shown to allow an efficient translation of the h-
galactosidase gene concomitant to the transgene expression
(Li et al., 1997).
DPW1 expression does not affect myogenesis in vitro
We transiently transfected C2C12 myoblasts with myo-
genin-DPW1 and compared with cells transfected with the
empty vector (no DPW1) driving IRES lacZ under the same
regulatory elements. As expected, both constructs do not
show detectable h-galactosidase expression in proliferating
myoblasts maintained in growth conditions (GM), however
1 and 2 days after cells are induced to differentiate (DM),
blue myotubes are easily detected with both constructs
(Fig. 1). No obvious difference was seen in the differ-
entiation capacity of myoblasts expressing DPW1 as
compared to the empty vector suggesting that ectopic
expression of DPW1 does not interfere with normal myo-
genesis. Similar results have been obtained when DPW1 is
driven by the CMV promoter (data not shown).
DPW1 is transiently expressed during the embryonic
myogenic program
To verify proper expression of myogenin-DPW1 in
vivo and to test whether embryonic transgene expression
results in overt muscle phenotypes, we generated founder
transgenic embryos by pronuclear injection and the
expression pattern of the transgene was followed by
detection of h-galactosidase activity. At embryonic day
10.5 (ED10.5), h-galactosidase expressing cells were
readily detected in the somite (Fig. 1). We observed
however that h-galactosidase activity declined during
myotome differentiation (Fig. 1) and at later stages, only
weak expression could be detected in pre-muscle masses
N. Nicolas et al. / Developmental Biology 281 (2005) 171–183176in the developing limbs and other processes (data not
shown). While the mechanism underlying the loss of
transgene expression at later stages of development is
unclear, we note that no overt malformation of muscle
masses could be observed in these founder embryos.
Histological analyses of the stained cells in the somite
region showed no obvious abnormalities (data not shown)
although we were unable to follow the fate of the cells
expressing the transgene. A similar transient transgene
expression pattern has been reported in a study in which
MRF4 was placed under the control of the myogenin
promoter (Zhu and Miller, 1997).
Postnatal growth is compromised in DPW1 transgenic mice
Since myogenin-DPW1 founder embryos appeared
normal, we set out to generate stable transgenic lines using
our transgene construct. We noted that few transgenic mice
survived past weaning suggesting that transgene expression
results in perinatal lethality. We thus genotyped pups soon
after birth and found that founder transgenic pups were
present in higher numbers at birth and failed to survive pastFig. 2. Postnatal growth defect of the transgenic mice and penetrance of the pheno
(right) pups showing postnatal growth deficit as compared to wildtype littermates
difference ( P b 0.1) in body weights. Note that pups do grow and develop hair2–3 weeks with the peak of mortality around 1 week after
birth. In contrast, few non-transgenic pups were lost after
birth. Furthermore, as each transgenic pup results from an
independent pronuclear injection and thus independent
integration events, we conclude that the perinatal lethality
is due solely to transgene expression. As we could obtain
transgenic founders with relatively high frequency, we
investigated the effects of the transgene further by setting
up multiple rounds of pronuclear injections and analyzing
early postnatal stages. This approach was feasible since we
could obtain transgenic pups with over 30% efficiency (20/
65) of which 50% of the transgenic pups (10/20) showed a
profound postnatal phenotype (Fig. 2). Specifically, we
note that by 5–7 days after birth, transgenic mice fail to
show significant body growth and are only 60% as large as
their wildtype siblings (Fig. 2). We note that transgenic
pups undergo modest growth, are able to feed and grow
body hair although their movements are spastic and
uncoordinated. Only a small number of transgenic mice
survive past 1 week, however the surviving transgenic pups
continue to grow but do not catch up in size and ultimately
die.type. (a) 3 days, 6 days and 15 days postnatal wildtype (left) and transgenic
. (b) Statistical analyses of 6 days postnatal pups (n = 3) show a significant
and other characteristics typical of postnatal maturation.
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mice
We performed a more detailed analysis of hindlimb
muscles at 6 days after birth using founder analysis to assure
an adequate number of transgenic pups for our study. At 6
days postnatal, transgenic pups nurse adequately and still
appear healthy although they begin to show a clear
difference in body size (Fig. 2). Cross-sections at the
midlevel of the hindlimbs revealed that, while overall bone
diameters were normal, the muscle masses were notably
smaller (Fig. 3). We note that all muscle groups are present
and correctly organized although the soleus appeared less
affected as compared to the tibialis (Fig. 3). Counts of fiber
number revealed no significant change (data not shown)
however measurements of fiber size (area) revealed a 60%
decrease as compared to wildtype siblings (Fig. 3). A
similar decrease in fiber size was also observed in other
muscles including dorsal musculature and the intercostal
muscles as well as a severe reduction of the diaphragm (data
not shown) which may ultimately account for the postnatal
mortality. We noted that cells in a satellite cell position
(closely associated with myofibers) with condensed hetero-
chromatic nuclei could be easily detected in wildtype
muscles (Fig. 3). Cells in a similar anatomical location
(dsatelliteT) could be readily observed in the transgenic
muscle samples although the nuclei were enlarged and
euchromatic (Fig. 3). As satellite cells can only be identified
rigorously based upon specific morphological criteria which
require higher resolution than possible in our semithin
plastic sections (Mauro, 1961; Oustanina et al., 2004; Seale
et al., 2000), we used electron microscopy to examine
sublaminar nuclei in wildtype and transgenic 6 days
postnatal hindlimb muscles (Fig. 4). At this early postnatal
stage, satellite cells are more numerous as compared to later
postnatal stages (Oustanina et al., 2004) presumably
reflecting perinatal secondary or tertiary myofiber formation
and maturation including the addition of more myonuclei
which also occurs under the basal lamina (McLennan, 1983;
Ontell, 1986; Ontell and Kozeka, 1984a,b; Ontell et al.,
1982, 1988; Zhang and McLennan, 1995, 1998). Nonethe-Fig. 3. Skeletal muscle fibers are smaller and possess a decreased number of
quiescent satellite cells. (a) Hematoxylin–eosin stained cross-sections of
hindlimbs at the midanterior–posterior level of 6 days postnatal pups (scale
bar = 3 mm). All muscle groups are formed and correctly organized;
however muscle masses show a reduced size. The soleus appeared less
affected as compared to the tibialis. (b) Semithin plastic sections of 6 days
postnatal hindlimb cross-section of a wildtype (b) and transgenic (c) pup at
the midanterior–posterior level (scale bar = 10 Am). Presumptive satellite
cells located peripherally to the myofiber with condensed heterochromatic
nuclei are easily detected in wildtype muscles (red arrows, b), while
numerous cells in a satellite cell position with euchromatic nuclei are
observed in the transgenic muscles (red arrows, c). Green arrows in panels b
and c indicate interstitial cells. (d) Measurements of the muscle fiber area
reveal a 60% decrease in the mean fiber area of transgenic (tg) muscles as
compared to wildtype (wt) siblings at 6 days postnatal ( P b 0.1).less, we can detect morphologically normal satellite cells in
wildtype 6 days postnatal muscle (Fig. 4). We therefore
counted the number of cells in the satellite cell position and
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wildtype and 3 transgenic gastrocnemius muscles which
were cross-sectioned at the midlevel of the muscle length.
The counting was performed on at least 10 different fields
per ultrathin section which was analyzed and photographed
using TEM. Sublaminal nuclei which were separated by a
plasma membrane from the adjacent myofibers were
counted and normalized to the number of fibers. As we do
not see a change in fiber number but only in fiber size, this
allowed us to determine if the overall number of satelliteFig. 4. Transgenic muscles display a change in satellite cell morphologies.
(a–f) Transmission electron micrographs of 6 days postnatal hindlimb
cross-sections obtained from midanterior–posterior hindlimb levels. (a)
Typical satellite cell with condensed heterochromatic nucleus is in wildtype
muscle. (b) Inset from panel a shows the paucity of cytoplasm and
membrane boundary between the satellite cell and adjacent myofiber
(arrows). (c, e) Cross-sections from hindlimb muscles taken from 2
different transgenic mice with corresponding insets shown at higher
resolution (d, f). Sublaminal cells with euchromatic (uncondensed) nuclei
can be detected containing more cytoplasm and organelles as compared to
wildtype satellite cells (compare panels c, e with a). Arrows in panels d and
f point to a clear cytoplasmic separation between the satellite cell and
adjacent myofiber although fusion may be occurring in panel d. Panels e
and corresponding inset (f) show a typical cell cluster found in the satellite
cell position in the transgenic muscles which are rarely observed in the
wildtype muscle. (g) Counts of quiescent (heterochromatic) cells normal-
ized to number of muscle fibers reveal a marked and significant decrease in
quiescent satellite cells in the transgenic muscles as compared to wildtype
muscles coincident with a marked increase in activated sublaminal cells
(*, **P b 0.05). All counts were normalized to the number of myofibers
(see Materials and methods for details). No change was observed in
myonuclei nor interstitial cells nor was a change in the overall proportion
of sublaminal satellite cells.cells was different between wildtype and transgenic
muscles. We also counted interstitial cells which were
outside of the myofiber basal lamina as well as the number
of myonuclei which were also normalized to the total
number of myofibers. No significant differences were
observed between wildtype and transgenic muscles with
regard to the number of myonuclei or interstitial cells (Fig.
4). However, we found that, while the wildtype and
transgenic muscles had the same number of cells under
the basal lamina and thus in a satellite cell position, the
transgenic muscle had a high percentage of these cells that
displayed euchromatic nuclei as well as more cytoplasm,
cellular extensions and organelles as compared to wildtype
tissue suggesting that satellite cells either fail to enter cell
cycle arrest or are activated myocytes as described by others
(Bischoff, 1975, 1986a,b, 1990). Thus, in order to quantify
our data, we considered sublaminar nuclei of either bonafide
satellite cells and/or satellite-like cells in order to assess if
the satellite cell population was changed. We found that,
while the total number of satellite cells normalized to fiber
number was unchanged, there was a striking decrease in the
percentage of quiescent satellite cells in the transgenic
muscles (P b 0.05). We further note that these cells are
often present as clusters of 3–5 cells (Figs. 4 and 5). Thus,
while transgenic muscle shows an apparent increase in
dactivatedT myocytes, there does not seem to be an overall
change in the number of satellite and satellite-like cells
suggesting that the transgenic muscle is not undergoing
stem cell recruitment typical of regenerating muscle and that
the smaller muscle mass in the transgenic mice may reflect
perturbations in other aspects of stem cell behavior such as
participating in postnatal maturation.
Pax7 is a reliable molecular marker of satellite cells in
postnatal muscle (Polesskaya et al., 2003; Seale et al., 2000,
2004b). We note that the Pax7 mutant mice display a similar
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et al., 2000). One potential cause of the reduced muscle
mass in the Pax7 mutant mice is either a major reduction in
the number of satellite cells in postnatal muscle that
participate in postnatal muscle growth (Seale et al., 2000)
or the ability of these cells to undergo proper renewal and
propagation (Oustanina et al., 2004). Given the critical role
of Pax7 in normal muscle stem cell behavior, we used triple
immunofluorescence confocal microscopy to examine the
expression of Pax7 and PW1 in combination with an
antibody to laminin to define the myofiber basal lamina
(Fig. 5). Previous studies revealed that PW1 protein islocalized primarily to the nuclei of myoblasts and nascent
myotubes in vitro as well as during early development
(Coletti et al., 2002; Relaix et al., 1996). Ongoing studies
examining PW1 expression in postnatal muscle reveal that
PW1 localizes to both satellite and a subset of interstitial
cells closely associated with the myofibers and levels rise
sharply in response to damage (manuscript in preparation
and results shown here). We note that PW1 is not expressed
in the interstitial cells of non-muscle tissues examined
suggesting that these cells are not simply connective tissue
components but may represent a non-satellite cell stem cell
compartment. Consistent with these studies, we find that
wildtype muscle shows clear PW1 and Pax7 expression and
that a subset of cells express both markers (Fig. 5). While
some Pax7 and PW1 positive cells are present in small
dclustersT in wildtype muscle, the majority of cells appear as
single cells that either express PW1, Pax7 or both (Fig. 5).
In marked contrast, transgenic muscle displays clusters of
cells expressing PW1 and/or Pax7 and they are present in
clusters of multiple cells (Fig. 5). The antibody we had
previously generated to PW1 is directed to the C-terminal
part of the protein (Relaix et al., 1996), therefore the
staining observed in the transgenic muscle corresponds only
to endogenous PW1. While the staining appears to represent
an increase in cells that stain for Pax7 and or PW1, we note
that our counts of satellite and interstitial cells indicate that
this is simply due to the overall smaller fiber size which
gives rise to an apparent increase in nuclear density per
field. We note that many clusters of labeled cells contain
Pax7/PW1+ cells as well as heterogeneous clusters of cells.
This result suggests that resident stem cells divide in situ
and generate both Pax7 and PW1 expressing cells and that
transgenic muscle contains an actively dividing and
increased stem cell population. Additionally, no expression
of the transgene was observed by PCR on postnatal muscle
(data not shown and see Zhu and Miller, 1997).
The decreased muscle mass in the DPW1 mice is not
only reminiscent of the Pax7 mutant mice but also may
result from a more general muscle wasting or atrophy. SuchFig. 5. Expression of Pax7 (a satellite cell marker) and PW1 is expressed in
transgenic muscle cell dclustersT. 6 days postnatal muscle sections processed
for dapi (blue) to visualize nuclei and stained using immunofluorescence
for Pax7 (red) and PW1 (green) and laminin (orange-yellow). Images were
captured using a confocal microscope at 100. Left column of panels a, c, e
and g show DAPI, Pax7 and PW1 only whereas the right column (b, d, f, h)
show laminin and dapi to orient cells with relation to the basal lamina. (a–d)
Representative sections from wildtype muscle at 6 days showing typical
colocalization of PW1 with Pax7 (yellow staining) whereas other cells are
stained for PW1 alone. Comparing the labeled cells in panels a and c with
panels b and d reveal a clear sublaminar localization of the nuclei which
express both Pax7 and PW1 or PW1 only. (e–h) Representative sections
from transgenic muscles at 6 days showing clusters of cells (marked by *)
expressing PW1 and/or Pax7. Yellow arrow in panel g shows cell co-
expressing both PW1 and Pax7 which is in a sublaminal position. We
note that the staining for laminin is less clear in the transgenics as
compared to wildtype and that many of the cells appear to traverse the
lamina. Scale bar = 4 Am.
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involve the specific induction of the E3 ligase, Atrogin-1/
MAFbx (Bodine et al., 2001; Gomes et al., 2001; Lecker,
2003). Given that PW1 participates in inflammatory
cytokine pathways such as TNFa-mediated NFnB activa-
tion (Relaix et al., 1998) and as chronic elevated levels of
inflammatory cytokines lead to cachexia (Fong et al., 1989;
Tisdale, 2001; Tracey and Cerami, 1992; Tracey et al.,
1988), we performed Northern analyses on mRNA obtained
from wildtype and transgenic muscles at 3, 5, 6 and 8 days
postnatal development. We observe that there is an elevated
expression of Atrogin-1 in the transgenic muscles however
by 6 days, we note some variation such that some transgenic
mice do not show elevated levels and by 8 days, levels
appear indistinguishable from wildtype muscles (Fig. 6). We
did not detect elevated levels of TNFa mRNA in the
transgenic muscle (data not shown), but we note that a large
array of inflammatory cytokines as well as non-cytokine
stimuli may lead to atrogin-1 upregulation (Gomes et al.,Fig. 6. Atrogin-1 levels are transiently elevated in transgenic muscles and
myoblasts display altered sensitivity to TNFa. (a) Detection of Atrogin-1
mRNA, a specific marker of muscle wasting by Northern blot. Atrogin-1
mRNA is highly expressed in transgenic hindlimb muscles at 3, 5 and 6
days postnatal. Levels are high in 3 and 5 days postnatal muscles whereas
we note variation by 6 days and low levels by 8 days postnatal
development. None of the wildtype muscles showed high levels of Atrogin
at any stage. Blots were hybridized with GAPDH to verify the homogeneity
of the mRNA loading. (b) Quantitative analysis of myogenic differentiation
reveals that both wildtype and transgenic myoblasts show robust differ-
entiation under normal conditions, only wildtype myoblasts show a strong
inhibition of differentiation in response to exogenous TNFa. Primary cells
from 3 different transgenic and wildtype mice were established from 6 day
postnatal muscles and tested for differentiation in the presence or absence of
TNFa. Multiple fields were counted for total nuclei and number of nuclei in
myosin positive myotubes. Data are presented as percentage of nuclei in
biochemically differentiated myotubes.2001; Sandri et al., 2004; Spate and Schulze, 2004). Our
previous studies revealed that PW1 plays a key role in
mediating the responses of myoblasts to TNFa (Coletti et
al., 2002). Specifically, when myogenic cell lines or primary
myoblasts are grown in the presence of exogenous TNFa,
differentiation is blocked and this response depends upon
PW1 and specific p53 downstream effectors including bax
and caspase 9 (Coletti et al., 2002). We therefore obtained
primary myoblasts from 3 independent wildtype and trans-
genic 6 days postnatal limb muscles and tested early passage
cells for their response to TNFa. As reported previously
(Coletti et al., 2002), wildtype cells showed robust differ-
entiation in standard differentiation media conditions (DM)
but differentiation was reduced when cells were placed in
DM supplemented with TNFa (Fig. 6). In contrast,
myoblasts obtained from transgenic mice showed normal
differentiation in both the absence and presence of
exogenous TNFa (Fig. 6).Discussion
Postnatal growth is affected by overexpression of DPW1
during embryogenesis
In this study, we show that ectopic expression of DPW1
during embryonic development affects postnatal growth. A
similar phenotype has been described for the Pax7 mutant
mice which fail to grow normally after birth (Seale et al.,
2000). In Pax7 mutant mice, satellite cell formation is
impaired but secondary fibers form correctly. In contrast,
we see that cells in a satellite cell position (sublaminal but
distinct from the myofiber) which express Pax7 are easily
detected in transgenic muscles, but the number of cells which
show a typical satellite cell morphology including a
condensed heterochromatic nuclei and low cytoplasmic and
organelle content is greatly reduced. In contrast, there is a
compensatory increase in sublaminal cells that appear as
activated myocytes and are present in clusters of 2–4 cells in
the transgenic muscle. This pattern of expression in the
transgenic muscle, combined with the observation that, in
both wildtype and transgenic muscles, some cells express
both markers, suggests that PW1 plays a role in governing
stem cell numbers and behavior.We note that in a recent study
examining explanted muscle fibers, similar dclustersT of
muscle stem cells have been described following damage
which contain cells that either express MyoD, Pax7 or both
(Zammit et al., 2004). These authors propose that the
different patterns of expression of these genes reflect an
asymmetric cell fate that determines if stem cells return to a
quiescent state or are determined to terminally differentiate
into muscle fibers (Zammit et al., 2004). Deregulation of
muscle stem cell behavior has also been observed in mice
lacking the forkhead/winged helix protein, MNF and like
DPW1 transgenic mice in our studies and Pax7 mutant mice,
MNF mutant mice are runted at birth (Garry et al., 2000).
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satellite cell behavior are otherwise normal with the
exception that mutant mice are often runted and fail to
achieve normal postnatal body size (Rudnicki et al., 1992;
White et al., 2000; Yablonka-Reuveni et al., 1999). We note
that, for each genotype, the overall body growth is
compromised even though each mouse shows a different
severity of the phenotype. Taken together, we conclude that
postnatal muscle stem cells are critical in the postnatal growth
of muscle and in turn can control overall body growth.
PW1 expression is associated with stem cell differentiation
Recent studies indicate that bone-marrow-derived muscle
stem cells (BMDSCs) participate in the formation of
satellite cells and muscle fibers (Asakura et al., 2002;
Dreyfus et al., 2004; Ferrari et al., 1998; Musaro et al.,
2004; Polesskaya et al., 2003; Rudnicki, 2003; Seale et al.,
2003) as well as cells originating from embryonic dorsal
aorta (De Angelis et al., 1999; Minasi et al., 2002). While
the involvement of BMDSCs has been well documented
during regeneration, their involvement in postnatal growth
has not been demonstrated to date. We note however that
Pax7 mutant postnatal muscle possesses a population of
cells which express identical cellular markers seen in
BMDSCs and that this population of cells display an
increased potential to differentiate along the hematopoietic
lineage (Seale et al., 2000). In addition, it has also been
demonstrated that pluripotent cells can originate from
vascular tissue (mesoangioblasts) that have strong myogenic
potential (De Angelis et al., 1999). Ongoing studies in our
laboratory reveal that mesoangioblasts as well as cells
localized in vascular tissue in muscle express PW1 (study in
preparation). Thus, the localization of PW1 expression to
satellite cells (Pax7+), interstitial cells and vascular cells is
highly consistent with a role in regulating some aspect of
pluripotent stem cell behavior.
DPW1 induced postnatal muscle atrophy
We observe that transgenic muscle appears atrophic and
has smaller fiber diameters. Consistent with this morpho-
logical observation, we find that transgenic muscle
expresses high levels of Atrogin-1 mRNA, a specific
marker of muscle atrophy. The molecular mechanisms
responsible for muscle atrophy are just beginning to be
understood. While a significant number of studies support
the model that various factors such as inflammatory
cytokines (TNF, IL), starvations or denervation lead to an
increase in protein catabolism in existing muscle fibers
(Tisdale, 2001; Tracey and Cerami, 1992; Tracey et al.,
1988), it is possible that these same factors also impede
muscle regeneration or the ability of myogenic stem cells to
fuse to pre-existing myofibers which may ultimately
contribute to the atrophic outcome. Indeed, we and others
have demonstrated that TNFa is a potent blocker ofmyogenic differentiation (Coletti et al., 2002; Grounds and
Torrisi, 2004; Li, 2003; Li and Reid, 2000). In this study, we
find that myogenic cells obtained from transgenic pups
display robust terminal differentiation in the presence of
TNFa as compared to wildtype which suggests that a
modification of transgenic muscle stem cell behavior
contributes to the muscle phenotype.
Our finding that the transgenic mice have atrophic
muscle and an increase proportion of the muscle stem cell
population in an activated state would seem paradoxical.
However, it was observed that denervation, which also leads
to muscle atrophy, is followed immediately by a transient
wave of satellite cell proliferation however no new muscle is
formed nor satellite cell nuclei enter into myofibers already
present (McLennan, 1983). In addition, we see no increase
in the proportion of sublaminal cells in the transgenic
muscles which suggests that this population is not expand-
ing as it would during secondary fiber formation or
regeneration. Indeed, whereas satellite cells proliferate
transiently after denervation in normal muscle, their number
sharply declines in long-term denervated muscle (Rodrigues
Ade et al., 2002) suggesting that satellite cell activation can
precede eventual satellite cell loss. We found that neither
MyoD transcripts nor protein levels are high in transgenic
muscles (data not shown) consistent with a mechanism
whereby satellite cells are activated but do not participate in
further myogenesis.
We note that the satellite cells are activated under
pathological conditions in which the muscle is degenerating
which triggers a regenerative response. For example, in the
case of the mdx mouse carrying a mutation corresponding to
the human muscular dystrophy Duchenne gene, over time
the muscle also consists of small myotubes with activated
satellite cells. This would suggest that the transgenic muscle
is not atrophic but merely undergoing successive rounds of
regeneration. We believe this not to be the case however
since mdx muscle does not express abnormally high levels
of Atrogin-1 (personal communication D. Glass). It is of
interest however that exposure of mdx muscle to antibody
reagents that block endogenous TNFa appears to protect
myofiber integrity (Grounds and Torrisi, 2004).
Transient expression of DPW1 during early development
affects satellite cell formation
The myogenin promoter used for this study has been
shown to be expressed in myogenic precursors in the
myotome and limb buds. At later stages however, only few
fibers show expression for this promoter construct despite
the fact that endogenous myogenin expression is much
higher (Cheng et al., 1995). Similarly, it was demonstrated
that transgenic mice in which MRF4 was placed under the
control of the same myogenin regulatory elements used for
our study (Zhu and Miller, 1997), MRF4 expression
declined during fetal development. Since we find that the
myog-DPW1 transgenic mice show a similar spatial and
N. Nicolas et al. / Developmental Biology 281 (2005) 171–183182temporal pattern of expression, we conclude that the decline
in transgene expression reflects the regulatory elements used
and is not influenced by DPW1 expression. Since we see
such robust and clear expression of the transgene at 10.5
days of embryonic development at the level of the somite
which later declines, we propose that this transient
expression underlies the phenotypic effects that become
apparent only after birth although verification of this awaits
the generation of conditional alleles. Our analyses of the
transgenic mice reveal a distinct change in the myogenic
cells in situ. Whether or not postnatal muscle stem cells are
specified at the level of the somite when the DPW1
transgene is expressed remains to be determined. We note
that, while stem cells are present in the transgenic muscle,
they appear to fail to enter growth arrest and do not respond
to exogenous TNFa once isolated in culture suggesting that
these cells are either permanently changed or represent a
different population due to events during early somito-
genesis. While it is unclear how this change in cytokine
responsivity contributes to the overall muscle phenotype
observed in the transgenic mice, these observations reveal
that the behavior of postnatal myogenic cells is altered due
to prior transgene expression in the embryo. These data
suggest that components of the TNFa–NFnB and/or p53
pathway may play a critical role during early development
in specifying the identify and/or behavior of postnatal stem
cells. Furthermore, these studies raise the interesting
hypothesis that deregulation of normal stem cell behavior
can trigger muscle atrophy.Acknowledgments
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